MEP53908A - Improved method of making nevirapine - Google Patents
Improved method of making nevirapineInfo
- Publication number
- MEP53908A MEP53908A MEP-539/08A MEP53908A MEP53908A ME P53908 A MEP53908 A ME P53908A ME P53908 A MEP53908 A ME P53908A ME P53908 A MEP53908 A ME P53908A
- Authority
- ME
- Montenegro
- Prior art keywords
- cyclopropylamino
- bromine
- give
- pyridinecarbonitrile
- halo
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/84—Nitriles
- C07D213/85—Nitriles in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- AIDS & HIV (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US39269002P | 2002-06-28 | 2002-06-28 | |
YUP-1102/04A RS50900B (sr) | 2002-06-28 | 2003-06-02 | Postupak za pripremanje nevirapina |
PCT/US2003/017376 WO2004002988A1 (en) | 2002-06-28 | 2003-06-02 | Improved method of making nevirapine |
Publications (1)
Publication Number | Publication Date |
---|---|
MEP53908A true MEP53908A (en) | 2011-05-10 |
Family
ID=30000920
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MEP-539/08A MEP53908A (en) | 2002-06-28 | 2003-06-02 | Improved method of making nevirapine |
Country Status (30)
Country | Link |
---|---|
US (1) | US6680383B1 (xx) |
EP (1) | EP1519936B1 (xx) |
JP (1) | JP4209388B2 (xx) |
KR (1) | KR100981261B1 (xx) |
CN (1) | CN1280293C (xx) |
AR (1) | AR039771A1 (xx) |
AT (1) | ATE382621T1 (xx) |
AU (1) | AU2003237336B2 (xx) |
BR (1) | BR0312071A (xx) |
CA (2) | CA2480046C (xx) |
DE (1) | DE60318444T2 (xx) |
DK (1) | DK1519936T3 (xx) |
EA (1) | EA007497B1 (xx) |
EC (1) | ECSP045514A (xx) |
ES (1) | ES2299709T3 (xx) |
HK (1) | HK1080848A1 (xx) |
HR (1) | HRP20041214A2 (xx) |
IL (1) | IL163977A0 (xx) |
ME (1) | MEP53908A (xx) |
MX (1) | MXPA04010405A (xx) |
MY (1) | MY131847A (xx) |
NO (1) | NO329109B1 (xx) |
NZ (1) | NZ537803A (xx) |
PE (1) | PE20040586A1 (xx) |
PL (1) | PL371496A1 (xx) |
RS (1) | RS50900B (xx) |
TW (1) | TWI270548B (xx) |
UA (1) | UA80140C2 (xx) |
WO (1) | WO2004002988A1 (xx) |
ZA (1) | ZA200407107B (xx) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007010352A1 (en) * | 2005-07-19 | 2007-01-25 | Emcure Pharmaceuticals Limited | An improved process for industrial manufacture of nevirapine |
JP2007031391A (ja) * | 2005-07-29 | 2007-02-08 | Koei Chem Co Ltd | アルキルアミノピリジンカルボニトリルの製造方法 |
BR112012014762A2 (pt) * | 2009-12-17 | 2016-03-29 | Univ Northwest | forma polimorfa de nevirapina e sua preparação |
CN102167699A (zh) * | 2011-03-17 | 2011-08-31 | 湖南博奥德生物医药技术开发有限公司 | 一种奈韦拉平制备方法 |
WO2012168949A2 (en) * | 2011-06-06 | 2012-12-13 | Laurus Labs Private Limited | A process for preparation of nevirapine |
CN102321015A (zh) * | 2011-06-30 | 2012-01-18 | 江苏德峰药业有限公司 | 一种抗艾滋病药物奈韦拉平关键中间体 2-(环丙胺基)-3-甲酸吡啶的制备方法 |
WO2016118586A1 (en) * | 2015-01-20 | 2016-07-28 | Virginia Commonwealth University | Lowcost, high yield synthesis of nevirapine |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5366972A (en) * | 1989-04-20 | 1994-11-22 | Boehringer Ingelheim Pharmaceuticals, Inc. | 5,11-dihydro-6H-dipyrido(3,2-B:2',3'-E)(1,4)diazepines and their use in the prevention or treatment of HIV infection |
DE4403311C1 (de) * | 1994-02-03 | 1995-04-20 | Boehringer Ingelheim Kg | Verfahren zur Herstellung von Nevirapine (11-Cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido[3,2-b:2',3'-e][1,4-diazepin]-6-on) |
-
2003
- 2003-02-06 UA UAA200500685A patent/UA80140C2/uk unknown
- 2003-06-02 BR BR0312071-6A patent/BR0312071A/pt not_active IP Right Cessation
- 2003-06-02 ES ES03736801T patent/ES2299709T3/es not_active Expired - Lifetime
- 2003-06-02 CA CA2480046A patent/CA2480046C/en not_active Expired - Fee Related
- 2003-06-02 JP JP2004517609A patent/JP4209388B2/ja not_active Expired - Fee Related
- 2003-06-02 EA EA200401535A patent/EA007497B1/ru not_active IP Right Cessation
- 2003-06-02 MX MXPA04010405A patent/MXPA04010405A/es active IP Right Grant
- 2003-06-02 AT AT03736801T patent/ATE382621T1/de active
- 2003-06-02 IL IL16397703A patent/IL163977A0/xx not_active IP Right Cessation
- 2003-06-02 KR KR1020047021296A patent/KR100981261B1/ko not_active IP Right Cessation
- 2003-06-02 ME MEP-539/08A patent/MEP53908A/xx unknown
- 2003-06-02 DE DE60318444T patent/DE60318444T2/de not_active Expired - Lifetime
- 2003-06-02 PL PL03371496A patent/PL371496A1/xx not_active IP Right Cessation
- 2003-06-02 NZ NZ537803A patent/NZ537803A/en not_active IP Right Cessation
- 2003-06-02 CN CNB038105896A patent/CN1280293C/zh not_active Expired - Fee Related
- 2003-06-02 DK DK03736801T patent/DK1519936T3/da active
- 2003-06-02 EP EP03736801A patent/EP1519936B1/en not_active Expired - Lifetime
- 2003-06-02 RS YUP-1102/04A patent/RS50900B/sr unknown
- 2003-06-02 CA CA2708442A patent/CA2708442C/en not_active Expired - Fee Related
- 2003-06-02 AU AU2003237336A patent/AU2003237336B2/en not_active Ceased
- 2003-06-02 WO PCT/US2003/017376 patent/WO2004002988A1/en active IP Right Grant
- 2003-06-05 US US10/454,991 patent/US6680383B1/en not_active Expired - Lifetime
- 2003-06-26 PE PE2003000642A patent/PE20040586A1/es not_active Application Discontinuation
- 2003-06-27 TW TW092117662A patent/TWI270548B/zh not_active IP Right Cessation
- 2003-06-27 MY MYPI20032417A patent/MY131847A/en unknown
- 2003-06-27 AR ARP030102323A patent/AR039771A1/es unknown
-
2004
- 2004-09-06 ZA ZA200407107A patent/ZA200407107B/en unknown
- 2004-10-12 NO NO20044332A patent/NO329109B1/no not_active IP Right Cessation
- 2004-12-27 HR HR20041214A patent/HRP20041214A2/xx not_active Application Discontinuation
- 2004-12-27 EC EC2004005514A patent/ECSP045514A/es unknown
-
2006
- 2006-01-18 HK HK06100817A patent/HK1080848A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RS50918B (sr) | Novi estri fluorenkarbonske kiseline, postupak za njihovo pripremanje, kao i njihova upotreba kao lekova | |
Goeminne et al. | Richter cyclization and co-cyclization reactions of triazene-masked diazonium ions | |
ATE411288T1 (de) | Aryl-, aryloxy- und alkyloxysubstituierte 1h- indol-3-yl-glyoxylsäurederivateals inhibitoren des plasminogenaktivatorinhibitors-1 (pai-1) | |
HUP0301954A2 (hu) | Orto-szubsztituált antranilsav-amidok és felhasználásuk gyógyszerként | |
EA200700545A1 (ru) | Производные изоксазолина и их применение в качестве гербицидов | |
CA2480356A1 (en) | Benzamide derivatives useful as histone deacetylase inhibitors | |
MEP53908A (en) | Improved method of making nevirapine | |
WO2001045483A3 (en) | Method for the preparation of pure citalopram | |
CA2524898A1 (en) | 6-arylmethyl-substituted pyrazolopyrimidines | |
RU2004133811A (ru) | Новые соединения | |
JP3858876B2 (ja) | 窒素含有芳香族ヘテロ環化合物カルボキサミドから対応するカルボン酸を製造する方法 | |
JP3046136B2 (ja) | 2−クロルピリジンの製法 | |
JPWO2006080401A1 (ja) | フッ素化プロリン誘導体の製造方法 | |
WO2000042016A1 (fr) | Fabrication de quinlinecarbaldéhyde | |
JPH03200769A (ja) | ピリジン塩素化物の製造法 | |
UY27865A1 (es) | Metodo mejorado para preparar nevirapina | |
Yu et al. | A mild and efficient method for aromatic chlorination of electron-rich arylalkyl amines | |
HUP9800871A1 (hu) | Szubsztituált alkének klórozása triklór-izocianurinsavval | |
JP2006512331A (ja) | 光化学ハロゲン化法 | |
TH67413A (th) | วิธีที่ปรับปรุงดีขึ้นสำหรับเตรียมเนวิราพีน | |
CN106117196A (zh) | 一种制备抗癌药物达沙替尼的方法 | |
JPH08301847A (ja) | 2−クロロ−3−置換ピリジンの製造法 | |
RU2223945C2 (ru) | Способ получения 2-аминобензофенона | |
JPH01193249A (ja) | アザタジン用中間体 | |
ES268522A1 (es) | Un procedimiento para la producción de nuevos ácidos antranílicos |